Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease intestinal disease
Comorbidity C0019158|hepatitis
Sentences 11
PubMedID- 20688604 Background: data on the prevalence of hepatitis c in patients with inflammatory bowel diseases (ibd) are limited and conflicting.
PubMedID- 20848488 hepatitis b reactivation in patients with inflammatory bowel disease: a prospective survey on screening and prevention practices at general hospitals in france.
PubMedID- 23664999 Factors predicting response to hepatitis b vaccination in patients with inflammatory bowel disease.
PubMedID- 21892694 Azathioprine induced hepatitis in patients with inflammatory bowel disease.
PubMedID- 22530631 Comparison of the effectiveness of two protocols for vaccination (standard and double dosage) against hepatitis b virus in patients with inflammatory bowel disease.
PubMedID- 26039133 Evaluation of factors associated with response to hepatitis b vaccination in patients with inflammatory bowel disease.
PubMedID- 25160690 Immunogenicity of hepatitis b vaccine in patients with inflammatory bowel disease and the benefits of revaccination.
PubMedID- 23354318 Improving care for inflammatory bowel disease patients infected with hepatitis b virus.
PubMedID- 23891915 Efficacy and safety of treatment of hepatitis c in patients with inflammatory bowel disease.
PubMedID- 25957555 Chronic bowel disease can co-exist with severe autoimmune hepatitis (aih) in an absence of primary sclerosing cholangitis.
PubMedID- 24162170 Prevalence of hepatitis-b viral markers in patients with inflammatory bowel disease in a hepatitis-b-endemic area: inadequate protective antibody levels in young patients.

Page: 1